COMPANY

Baebies

HQ: Durham, NC source · baebies.com ↗ · Southeast

Location: Durham, NC · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: covid-19 hepatitis c hyperbilirubinemia Influenza A Influenza Type B SARS CoV 2 Infection RSV Infection G6PD G6PD Deficiency hepatitis b hiv infection hypoglycemia galactosemia

2Trials (company is sponsor)50NIH grants

Funding and NIH signals

NIH award NIH awarded $1M (SBIR Phase II 5R44AI188680-03, continuation, notice Sep 9, 2026). NIH RePORTER 5R44AI188680-03 (Sep 9, 2026)
Evidence (1 event)
- Sep 9, 2026 · NIH RePORTER 5R44AI188680-03
  Organization: BAEBIES, INC.; City/State: DURHAM, NC; Project number: 5R44AI188680-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-09; FY total cost (award amount): 1000000; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Sep 9, 2026 Grant Government grant — SBIR: $1M (annual award, as published), announced Sep 9, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 10, 2026 Grant Government contract: $1.3M (total, as published), announced Jun 10, 2026. Agency: DoD. Source: government award database. source ↗
Sep 12, 2025 Grant Government grant — SBIR: $1M (annual award, as published), announced Sep 12, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Sep 1, 2025 Grant Government grant — NIH N43: $299,427 (annual award, as published), announced Sep 1, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Aug 28, 2025 Grant Government grant — SBIR: $999,362 (annual award, as published), announced Aug 28, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗
Mar 3, 2025 Grant Government contract: $249,849 (total, as published), announced Mar 3, 2025. Agency: DoD. Source: government award database. source ↗
Dec 17, 2024 Grant Government grant — SBIR: $300,000 (annual award, as published), announced Dec 17, 2024. Agency: NIH/NIAID. Source: government award database. source ↗
Nov 1, 2024 Grant Government grant — NIH N43: $2M (annual award, as published), announced Nov 1, 2024. Agency: NIH/NIAID. Source: government award database. source ↗
Oct 2, 2023 Trial start —: FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol source ↗
Nov 11, 2019 Trial start —: Comparative Evaluation of the FINDER Instrument and FINDER G6PD Cartridge in Adults and Neonates source ↗

Funding

Last 2 years.

Sep 9, 2026 Government grant — SBIR: $1M (annual award, as published), announced Sep 9, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 10, 2026 Government contract: $1.3M (total, as published), announced Jun 10, 2026. Agency: DoD. Source: government award database. source ↗
Sep 12, 2025 Government grant — SBIR: $1M (annual award, as published), announced Sep 12, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Sep 1, 2025 Government grant — NIH N43: $299,427 (annual award, as published), announced Sep 1, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Aug 28, 2025 Government grant — SBIR: $999,362 (annual award, as published), announced Aug 28, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗
Mar 3, 2025 Government contract: $249,849 (total, as published), announced Mar 3, 2025. Agency: DoD. Source: government award database. source ↗
Dec 17, 2024 Government grant — SBIR: $300,000 (annual award, as published), announced Dec 17, 2024. Agency: NIH/NIAID. Source: government award database. source ↗
Nov 1, 2024 Government grant — NIH N43: $2M (annual award, as published), announced Nov 1, 2024. Agency: NIH/NIAID. Source: government award database. source ↗

Clinical trials (lead sponsor) 2

Record	Title	Phase	Status	Start	Primary completion
NCT05928507	FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol	Not listed	Unknown status (ClinicalTrials.gov)	Oct 2, 2023	Feb 29, 2024 (estimated)
NCT04146246	Comparative Evaluation of the FINDER Instrument and FINDER G6PD Cartridge in Adults and Neonates	Not listed	Completed	Nov 11, 2019	Mar 13, 2020 (actual)

NIH awards 50

Annual award amounts. Total $40.6M.

Jul 15, 2024 NIH award 4R44HL169045-02 FY2024: $998,891 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. A Near-Patient, Low Blood Volume Platform for Rapid source ↗
Jun 28, 2024 NIH award 5R44HL162151-03 FY2024: $948,080 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. A Low Blood Volume Platform for Recurrent Anticoagu source ↗
2024 NIH contract (government contract; not a grant and not an investment round) 75N93024C00027-0-9999-1 FY2024: $299,982 awarded for that fiscal year; activity N43 (OTHER_NIH); PI NG, RAINER; recipient as written: BAEBIES, INC., DURHAM, NC. A Simple Multiplexed Pl source ↗
Aug 30, 2023 NIH award 5R44HL140662-08 FY2023: $863,466 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. Improving Anticoagulation Monitoring in Pediatric P source ↗
Jun 9, 2023 NIH award 4R44HL162151-02 FY2023: $830,640 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. A Low Blood Volume Platform for Recurrent Anticoagu source ↗
Apr 6, 2023 NIH award 1R44HL169045-01 FY2023: $299,999 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. A Near-Patient, Low Blood Volume Platform for Rapid source ↗
2023 NIH contract (government contract; not a grant and not an investment round) 75N93023C00006-0-9999-1 FY2023: $299,999 awarded for that fiscal year; activity N43 (OTHER_NIH); PI NG, RANIER; recipient as written: BAEBIES, INC., DURHAM, NC. A Multifunctional Point source ↗
Sep 7, 2022 NIH award 5R44HD102242-03 FY2022: $703,049 awarded for that fiscal year; activity R44 (SBIR); PI NG, RAINER; recipient as written: BAEBIES, INC., DURHAM, NC. Identification of glycosaminoglycans for newborn screening source ↗
Aug 24, 2022 NIH award 5R44AI157716-03 FY2022: $253,737 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. Rapid Differential Diagnosis of COVID-19 and Common source ↗
May 23, 2022 NIH award 1R44HL162151-01 FY2022: $266,110 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. A Low Blood Volume Platform for Recurrent Anticoagu source ↗
Apr 1, 2022 NIH award 5R44HL125484-06 FY2022: $995,038 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. Digital Microfluidics - Minimizing Blood Volume for source ↗
Mar 25, 2022 NIH award 5R44HL140662-07 FY2022: $878,833 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. Improving Anticoagulation Monitoring in Pediatric P source ↗
2022 NIH contract (government contract; not a grant and not an investment round) 75N93021C00048-P00003-9999-1 FY2022: $1,499,998 awarded for that fiscal year; activity N43 (OTHER_NIH); PI UNGEWITTER, ERICA; recipient as written: BAEBIES, INC., DURHAM, NC. Rapid, Po source ↗
Sep 20, 2021 NIH award 4R44AI157716-02 FY2021: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. Rapid Differential Diagnosis of COVID-19 and Comm source ↗
Sep 15, 2021 NIH award 4R44HD102242-02 FY2021: $628,742 awarded for that fiscal year; activity R44 (SBIR); PI NG, RAINER; recipient as written: BAEBIES, INC., DURHAM, NC. Identification of glycosaminoglycans for newborn screening source ↗
Jul 26, 2021 NIH award 5R44DA050375-03 FY2021: $672,757 awarded for that fiscal year; activity R44 (SBIR); PI NG, RAINER; recipient as written: BAEBIES, INC., DURHAM, NC. A Novel Workflow to Screen for Illicit Drug Exposure in Ne source ↗
Jun 2, 2021 NIH award 5R44HL140662-05 FY2021: $253,772 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. Improving Anticoagulation Monitoring in Pediatric P source ↗
Apr 30, 2021 NIH award 2R44HL140662-06 FY2021: $912,027 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. Improving Anticoagulation Monitoring in Pediatric P source ↗
Mar 23, 2021 NIH award 5R44HL125484-05 FY2021: $994,792 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. Digital Microfluidics - Minimizing Blood Volume for source ↗
Mar 23, 2021 NIH award 5R44HL146016-03 FY2021: $681,054 awarded for that fiscal year; activity R44 (SBIR); PI ELDERBROOM, JENNIFER; recipient as written: BAEBIES, INC., DURHAM, NC. An Innovative Unbound Bilirubin Assay to Identif source ↗
Feb 11, 2021 NIH award 1R44AI157716-01 FY2021: $278,148 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. Rapid Differential Diagnosis of COVID-19 and Common source ↗
2021 NIH contract (government contract; not a grant and not an investment round) 75N93021C00048-0-9999-1 FY2021: $299,983 awarded for that fiscal year; activity N43 (OTHER_NIH); PI UNGEWITTER, ERICA; recipient as written: BAEBIES, INC., DURHAM, NC. Rapid, Point-of- source ↗
Dec 18, 2020 NIH award 5R44HD094543-03 FY2021: $793,462 awarded for that fiscal year; activity R44 (SBIR); PI AMIN, VIREN R; recipient as written: BAEBIES, INC., DURHAM, NC. Feasibility and validation of an integrated newborn scr source ↗
Sep 1, 2020 NIH award 5R44HD072853-07 FY2020: $938,890 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. Multiplex Platform for Point-of-Care Newborn Screen source ↗
Aug 31, 2020 NIH award 2R44HL140662-04 FY2020: $214,063 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. Improving Anticoagulation Monitoring in Pediatric P source ↗
Aug 28, 2020 NIH award 1R44HD102242-01 FY2020: $194,426 awarded for that fiscal year; activity R44 (SBIR); PI NG, RAINER; recipient as written: BAEBIES, INC., DURHAM, NC. Identification of glycosaminoglycans for newborn screening source ↗
Aug 20, 2020 NIH award 5R44HD096981-03 FY2020: $717,391 awarded for that fiscal year; activity R44 (SBIR); PI NG, RAINER; recipient as written: BAEBIES, INC., DURHAM, NC. A Low Blood Volume Platform for Global Newborn Screening source ↗
Aug 7, 2020 NIH award 4R44DA050375-02 FY2020: $716,018 awarded for that fiscal year; activity R44 (SBIR); PI NG, RAINER; recipient as written: BAEBIES, INC., DURHAM, NC. A Novel Workflow to Screen for Illicit Drug Exposure in Ne source ↗
Jun 8, 2020 NIH award 5R44HD095713-03 FY2020: $666,412 awarded for that fiscal year; activity R44 (SBIR); PI AMIN, VIREN R; recipient as written: BAEBIES, INC., DURHAM, NC. A Comprehensive Newborn Screening Solution for Duchenne source ↗
Apr 3, 2020 NIH award 2R44HL125484-04 FY2020: $995,191 awarded for that fiscal year; activity R44 (SBIR); PI PAMULA, VAMSEE K.; recipient as written: BAEBIES, INC., DURHAM, NC. Digital Microfluidics - Minimizing Blood Volume for source ↗

Connect

See your connections at Baebies on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12